You are currently browsing the archives for 24 January 2017.
Displaying 1 entry.

Product line extensions for for additional clinical applications.

In the experience from thousands of clinical cases with the firm Morp Universal Deflectable guiding catheter platform is based, has the Morp AccessPro system has been developed to address a real clinical need for improved control and back support in therapeutic PAD method. Product line extensions for for additional clinical applications.

Researchers in Canada compared the risk of heart attack, heart failure and death in people with rosiglitazone and pioglitazone treated. They identified nearly 40,000 people aged 66 years and older, treatment with either rosiglitazone or pioglitazone started between April 2002 and March 2008.S. Food and Drug Administration of the steerable delivery system Morp AccessPro.